Compare Micron Technology, Inc. (MU) vs Pfizer Inc (PFE) Price & Performance

Micron Technology, Inc.Trade

Pfizer IncTrade

Price performance (Past 24H)

Key statistics

Micron Technology, Inc. vs Pfizer Inc — how do they compare? Micron Technology, Inc. trades at $981.4 (market cap $977.44B), while Pfizer Inc trades at $24.92 (market cap $141.06B). The key difference: Micron Technology, Inc. is far larger — about 6.9× Pfizer Inc's market cap, and Pfizer Inc pays the higher dividend (6.95%). Which is the better fit depends on your goals.

	MU	PFE
Market Cap	$977.44B	$141.06B
Sector	Technology	Health
52-Week High	$1.21K	$28.56
52-Week Low	$104.88	$23.29
Enterprise Value	$957.80B	$191.72B
Dividend Yield	0.06%	6.95%
Volume	—	29,869,932

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Micron Technology, Inc.

No Aura AI signal available yet.

Pfizer Inc

Pfizer (PFE) trades at $25.05, down 0.36% on the day, with a bullish technical signal supported by strong quarterly earnings beats. The company maintains solid profitability with a 73.51% gross margin and 11.83% net income margin, though revenue has moderated post-pandemic. Recent news highlights pipeline advancements in oncology and obesity treatments, positioning PFE for potential growth catalysts in 2026.

The outlook for Pfizer is cautiously optimistic, with a consensus price target of $28.25 offering 13% upside. Key opportunities include dividend stability and pipeline innovation, while risks involve patent cliffs and competitive pressures. Analyst sentiment is mixed with 38% buy ratings, reflecting balanced views on recovery potential versus near-term challenges.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

Micron Technology stock upgraded to Buy on AI-driven demand and strong Q3 revenue growth.Seeking Alpha · 6 hours agoBullish TSMC and ASML confirm strong AI memory demand; Micron backed by US-Japan for expansion amid supply limits.Seeking Alpha · 10 hours agoBullish Micron stock jumps 8% as analysts boost price targets on AI-driven memory chip demand.Finbold · 10 hours agoBullish View details →

PFE

Over 180 companies develop 200+ PD-1/PD-L1 inhibitors, reshaping cancer treatment landscape.Delveinsight · 4 hours agoBullish New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

About Micron Technology, Inc.

Micron historically focused on designing and manufacturing DRAM for PCs. The firm then expanded into the NAND flash memory market. It increased its DRAM scale with the purchase of Elpida (completed in mid-2013) and Inotera (completed in December 2016). The firm's DRAM and NAND products tailored to PCs, data centers, smartphones, game consoles, automotives, and other computing devices.

About Pfizer Inc

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.